Anteris Technologies, a prominent player in the medical technology industry, has set its sights on capturing a significant 4% share of the US transcatheter valve replacement market by 2030.

This ambitious goal has sparked a surge of interest among investors, who see tremendous potential in the company's innovative approach to addressing the growing demand for minimally invasive cardiac interventions.

Transcatheter valve replacement (TAVR) procedures have revolutionized the treatment of aortic valve stenosis, a prevalent heart condition that affects millions of older adults worldwide. - https://webmdnetwork.com/blog/anteris-technologies-us-transcatheter-valve-market/?unique_id_thfdec5f

Anteris Technologies Aims for Dominant Market Share in Transcatheter Valve Replacement by 2030